Genmab and Johnson & Johnson ‘love’ partnership as some ponder takeover
FILE PHOTO: Genmab Chief Executive Jan van de Winkel poses for a photograph in London, Britain, October 13, 2016. REUTERS/Ben Hirschler/File Photo LONDON (Reuters) – Genmab (GEN.CO) was Europe’s second biggest biotech company, until its partner Johnson & Johns... More »
